重度の大動脈不全で早期のミトラ弁閉塞のエコーカルディオグラフィの実証. その臨床的影響は,

E H Botvinick, N B Schiller, R Wickramasekaran

Circulation

|May 1, 1975

まとめ

早期ミトラ弁閉塞 (ECMV) は,重度の大動脈不全における重要なエコー心臓検査結果である. この兆候は,急性大動脈不全と,直ちに大動脈弁の置換の必要性を示す可能性があります.

科学分野:

心臓病学心臓病学
エコーカルディオグラフィーエコーカルディオグラフィー
バルブ性心疾患バルブ性心疾患とは

背景:

重度の大動脈不全は,複雑な血液動力学的変化につながる可能性があります.
エコーカルディオグラフィは,心臓病の診断とモニタリングに不可欠です.

研究の目的:

大動脈不全患者の早期ミトラ弁閉塞 (ECMV) の発生と重要性を調査する.
急性大動脈不全の指標と介入の必要性をECMVとして評価する.

主な方法:

大動脈不全の患者およびそれ以外の患者からのエコーカルディオグラフィのデータの遡及的分析.
臨床パラメータとのECMVの相関関係,NYHA機能クラスと血管学的重症度を含む.
ECMVサブタイプの分析と,オースティン・フリントのうなり声との関連.

主要な成果:

ECMVは,大動脈不全が確認された53人の患者のうち11人に確認されました.
"B型"ECMVは,後期ダイアストールで発生する.
ECMVは,急性大動脈不全と,大動脈弁置換後の左心室の縮小と強く関連していました.

結論:

ECMVは,急性,重度の大動脈不全の貴重なエコー心臓検査の兆候です.
ECMVは,緊急の大動脈弁置換を必要とする患者の非侵襲的指標として機能することができます.
ECMVの分析は,オースティン・フリントの騒音の仕組みを理解するのに役立ちます.

さらに関連する動画

04:48

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery

Published on: November 28, 2018

07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

関連する概念動画

01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...

01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...

01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...